White matter abnormalities in never-treated patients with long-term schizophrenia

Yuan Xiao, Huaiqiang Sun, Shulin Shi, Dan Jiang, Bo Tao, Youjin Zhao, Wenjing Zhang, Qiyong Gong, John A Sweeney, Su Lui

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

Objective: This study tested for differences of white matter integrity between treated and never-treated long-term schizophrenia patients, matched on illness duration, and for differential changes in relation to age in these two groups relative to healthy comparison subjects. Method: This cross-sectional diffusion tensor imaging study included 31 never-treated and 46 matched antipsychotic-treated patients with long-term schizophrenia and 58 healthy comparison subjects. Fractional anisotropy measures of white matter tracts were extracted and compared. Linear regression analysis was used to explore the association between age and fractional anisotropy among the three groups. Results: Fractional anisotropy significantly differed among the three groups in 14 of 20 white matter tracts defined in the Johns Hopkins University white matter template. Never-treated patients displayed greater reduction of fractional anisotropy than antipsychotic-treated patients in the left anterior thalamic radiation, the left cingulum-hippocampus pathway, the splenium and genu of the corpus callosum, and the left superior longitudinal fasciculus, and greater fractional anisotropy in the right uncinate fasciculus. Both patient groups showed multiple reductions relative to healthy comparison subjects. Never-treated patients showed an accelerated and clinically relevant age-related reduction of fractional anisotropy in the genu of the corpus callosum. Conclusions: These psychoradiological findings provide insight into the regional distribution of white matter deficits in the years after illness onset in long-term schizophrenia. Findings of greater impairments in never-treated patients, and a greater age-related reduction in the genu of the corpus callosum in these patients, suggest that long-term antipsychotic treatment does not adversely affect white matter tracts over the longer-term course of illness and may confer benefits.

Original languageEnglish (US)
Pages (from-to)1129-1136
Number of pages8
JournalAmerican Journal of Psychiatry
Volume175
Issue number11
DOIs
StatePublished - Nov 1 2018

Fingerprint

Anisotropy
Schizophrenia
Corpus Callosum
Antipsychotic Agents
Healthy Volunteers
Diffusion Tensor Imaging
White Matter
Linear Models
Hippocampus
Regression Analysis
Radiation

ASJC Scopus subject areas

  • Psychiatry and Mental health

Cite this

White matter abnormalities in never-treated patients with long-term schizophrenia. / Xiao, Yuan; Sun, Huaiqiang; Shi, Shulin; Jiang, Dan; Tao, Bo; Zhao, Youjin; Zhang, Wenjing; Gong, Qiyong; Sweeney, John A; Lui, Su.

In: American Journal of Psychiatry, Vol. 175, No. 11, 01.11.2018, p. 1129-1136.

Research output: Contribution to journalArticle

Xiao, Y, Sun, H, Shi, S, Jiang, D, Tao, B, Zhao, Y, Zhang, W, Gong, Q, Sweeney, JA & Lui, S 2018, 'White matter abnormalities in never-treated patients with long-term schizophrenia', American Journal of Psychiatry, vol. 175, no. 11, pp. 1129-1136. https://doi.org/10.1176/appi.ajp.2018.17121402
Xiao, Yuan ; Sun, Huaiqiang ; Shi, Shulin ; Jiang, Dan ; Tao, Bo ; Zhao, Youjin ; Zhang, Wenjing ; Gong, Qiyong ; Sweeney, John A ; Lui, Su. / White matter abnormalities in never-treated patients with long-term schizophrenia. In: American Journal of Psychiatry. 2018 ; Vol. 175, No. 11. pp. 1129-1136.
@article{198163c025ec4192b8433c9c55193ee8,
title = "White matter abnormalities in never-treated patients with long-term schizophrenia",
abstract = "Objective: This study tested for differences of white matter integrity between treated and never-treated long-term schizophrenia patients, matched on illness duration, and for differential changes in relation to age in these two groups relative to healthy comparison subjects. Method: This cross-sectional diffusion tensor imaging study included 31 never-treated and 46 matched antipsychotic-treated patients with long-term schizophrenia and 58 healthy comparison subjects. Fractional anisotropy measures of white matter tracts were extracted and compared. Linear regression analysis was used to explore the association between age and fractional anisotropy among the three groups. Results: Fractional anisotropy significantly differed among the three groups in 14 of 20 white matter tracts defined in the Johns Hopkins University white matter template. Never-treated patients displayed greater reduction of fractional anisotropy than antipsychotic-treated patients in the left anterior thalamic radiation, the left cingulum-hippocampus pathway, the splenium and genu of the corpus callosum, and the left superior longitudinal fasciculus, and greater fractional anisotropy in the right uncinate fasciculus. Both patient groups showed multiple reductions relative to healthy comparison subjects. Never-treated patients showed an accelerated and clinically relevant age-related reduction of fractional anisotropy in the genu of the corpus callosum. Conclusions: These psychoradiological findings provide insight into the regional distribution of white matter deficits in the years after illness onset in long-term schizophrenia. Findings of greater impairments in never-treated patients, and a greater age-related reduction in the genu of the corpus callosum in these patients, suggest that long-term antipsychotic treatment does not adversely affect white matter tracts over the longer-term course of illness and may confer benefits.",
author = "Yuan Xiao and Huaiqiang Sun and Shulin Shi and Dan Jiang and Bo Tao and Youjin Zhao and Wenjing Zhang and Qiyong Gong and Sweeney, {John A} and Su Lui",
year = "2018",
month = "11",
day = "1",
doi = "10.1176/appi.ajp.2018.17121402",
language = "English (US)",
volume = "175",
pages = "1129--1136",
journal = "American Journal of Psychiatry",
issn = "0002-953X",
publisher = "American Psychiatric Association",
number = "11",

}

TY - JOUR

T1 - White matter abnormalities in never-treated patients with long-term schizophrenia

AU - Xiao, Yuan

AU - Sun, Huaiqiang

AU - Shi, Shulin

AU - Jiang, Dan

AU - Tao, Bo

AU - Zhao, Youjin

AU - Zhang, Wenjing

AU - Gong, Qiyong

AU - Sweeney, John A

AU - Lui, Su

PY - 2018/11/1

Y1 - 2018/11/1

N2 - Objective: This study tested for differences of white matter integrity between treated and never-treated long-term schizophrenia patients, matched on illness duration, and for differential changes in relation to age in these two groups relative to healthy comparison subjects. Method: This cross-sectional diffusion tensor imaging study included 31 never-treated and 46 matched antipsychotic-treated patients with long-term schizophrenia and 58 healthy comparison subjects. Fractional anisotropy measures of white matter tracts were extracted and compared. Linear regression analysis was used to explore the association between age and fractional anisotropy among the three groups. Results: Fractional anisotropy significantly differed among the three groups in 14 of 20 white matter tracts defined in the Johns Hopkins University white matter template. Never-treated patients displayed greater reduction of fractional anisotropy than antipsychotic-treated patients in the left anterior thalamic radiation, the left cingulum-hippocampus pathway, the splenium and genu of the corpus callosum, and the left superior longitudinal fasciculus, and greater fractional anisotropy in the right uncinate fasciculus. Both patient groups showed multiple reductions relative to healthy comparison subjects. Never-treated patients showed an accelerated and clinically relevant age-related reduction of fractional anisotropy in the genu of the corpus callosum. Conclusions: These psychoradiological findings provide insight into the regional distribution of white matter deficits in the years after illness onset in long-term schizophrenia. Findings of greater impairments in never-treated patients, and a greater age-related reduction in the genu of the corpus callosum in these patients, suggest that long-term antipsychotic treatment does not adversely affect white matter tracts over the longer-term course of illness and may confer benefits.

AB - Objective: This study tested for differences of white matter integrity between treated and never-treated long-term schizophrenia patients, matched on illness duration, and for differential changes in relation to age in these two groups relative to healthy comparison subjects. Method: This cross-sectional diffusion tensor imaging study included 31 never-treated and 46 matched antipsychotic-treated patients with long-term schizophrenia and 58 healthy comparison subjects. Fractional anisotropy measures of white matter tracts were extracted and compared. Linear regression analysis was used to explore the association between age and fractional anisotropy among the three groups. Results: Fractional anisotropy significantly differed among the three groups in 14 of 20 white matter tracts defined in the Johns Hopkins University white matter template. Never-treated patients displayed greater reduction of fractional anisotropy than antipsychotic-treated patients in the left anterior thalamic radiation, the left cingulum-hippocampus pathway, the splenium and genu of the corpus callosum, and the left superior longitudinal fasciculus, and greater fractional anisotropy in the right uncinate fasciculus. Both patient groups showed multiple reductions relative to healthy comparison subjects. Never-treated patients showed an accelerated and clinically relevant age-related reduction of fractional anisotropy in the genu of the corpus callosum. Conclusions: These psychoradiological findings provide insight into the regional distribution of white matter deficits in the years after illness onset in long-term schizophrenia. Findings of greater impairments in never-treated patients, and a greater age-related reduction in the genu of the corpus callosum in these patients, suggest that long-term antipsychotic treatment does not adversely affect white matter tracts over the longer-term course of illness and may confer benefits.

UR - http://www.scopus.com/inward/record.url?scp=85056163046&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85056163046&partnerID=8YFLogxK

U2 - 10.1176/appi.ajp.2018.17121402

DO - 10.1176/appi.ajp.2018.17121402

M3 - Article

C2 - 30068259

AN - SCOPUS:85056163046

VL - 175

SP - 1129

EP - 1136

JO - American Journal of Psychiatry

JF - American Journal of Psychiatry

SN - 0002-953X

IS - 11

ER -